Kiromic Biopharma Strikes $2M Convertible Debt Deal for Growth
PremiumCompany AnnouncementsKiromic Biopharma Strikes $2M Convertible Debt Deal for Growth
8M ago
option delistings on September 25th
Premium
The Fly
option delistings on September 25th
1y ago
Kiromic BioPharma to switch trading from Nasdaq to OTC pink sheets
Premium
The Fly
Kiromic BioPharma to switch trading from Nasdaq to OTC pink sheets
1y ago
Kiromic BioPharma announces 1-for-30 reverse stock split
PremiumThe FlyKiromic BioPharma announces 1-for-30 reverse stock split
2y ago
Kiromic reports favorable Deltacel preclinical pharmacology results
Premium
The Fly
Kiromic reports favorable Deltacel preclinical pharmacology results
2y ago
Kiromic says ISS, Glass Lewis recommend stockholders vote for all proposals
Premium
The Fly
Kiromic says ISS, Glass Lewis recommend stockholders vote for all proposals
2y ago
Kiromic BioPharma CEO encourages stock split, sees Deltacel trial in 2Q23
PremiumThe FlyKiromic BioPharma CEO encourages stock split, sees Deltacel trial in 2Q23
2y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100